Current Options and Future Directions in Immune Therapy for Glioblastoma.

Front Oncol · 2018 · PMC6290347 · PMID 30568917

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

This trial showed a positive trend toward increased PFS in recurrent GBM patients ( 140 ).

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.